Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The AZD1222 COVID-19 vaccine showed a consistent safety profile over two years, but its efficacy waned, necessitating booster vaccinations for sustained protection against SARS-CoV-2 infection.
Area Of Science
- Vaccinology
- Infectious Diseases
- Clinical Trials
Background
- Understanding long-term COVID-19 vaccine performance is crucial.
- The AZD1222 (ChAdOx1 nCoV-19) vaccine's durability requires further investigation.
Purpose Of The Study
- To assess the 2-year safety, efficacy, and immunogenicity of the AZD1222 primary vaccination series.
- To evaluate the long-term immune response and protection against SARS-CoV-2.
Main Methods
- A phase 3, randomized, placebo-controlled study (NCT04516746) involving 32,450 participants.
- Two-year follow-up including safety assessments, efficacy endpoints, and immunogenicity measures (antibody titers).
Main Results
- No new safety concerns or thrombotic events were identified for AZD1222 over two years.
- Vaccine efficacy durability was confirmed up to 6 months; infection rates increased thereafter.
- Antibody titers showed waning over time, with elevated neutralizing antibodies at 1 year and anti-spike at 2 years.
Conclusions
- The AZD1222 vaccine demonstrates a favorable long-term safety profile.
- Waning immunity and efficacy highlight the need for ongoing COVID-19 booster vaccinations.
- The study supports continued surveillance and vaccination strategies for COVID-19.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...